Michael N. Dworzak

St. Anna Kinderspital
Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 152 publications

Incidence and Risk Factors of Symptomatic Osteonecrosis in Children With Acute Lymphoblastic Leukemia-A Population-Based Analysis of the Austrian ALL-BFM Study Group.

Incidence and Risk Factors of Symptomatic Osteonecrosis in Children With Acute Lymphoblastic Leukemia-A Population-Based Analysis of the Austrian ALL-BFM Study Group.

Journal: EJHaem

Published: January 13, 2026

Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 10, 2025

Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent years.

Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent years.

Journal: Blood advances

Published: September 09, 2025

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Journal: Blood advances

Published: September 09, 2025

Concurrent Juvenile Myelomonocytic Leukemia and Gliomas in Patients With Neurofibromatosis Type 1.

Concurrent Juvenile Myelomonocytic Leukemia and Gliomas in Patients With Neurofibromatosis Type 1.

Journal: Pediatric blood & cancer

Published: August 19, 2025

Evaluation of the Impact of Hydrogen Peroxide on ANFO-Based Materials' Morphology.

Evaluation of the Impact of Hydrogen Peroxide on ANFO-Based Materials' Morphology.

Journal: Materials (Basel, Switzerland)

Published: July 23, 2025

Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus.

Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus.

Journal: Clinical epigenetics

Published: June 02, 2025

Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy.

Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy.

Journal: HemaSphere

Published: May 27, 2025

Children with chronic-phase chronic myeloid leukemia: characteristics and outcomes from the International Registry of Childhood CML.

Children with chronic-phase chronic myeloid leukemia: characteristics and outcomes from the International Registry of Childhood CML.

Journal: Haematologica

Published: May 22, 2025

Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.

Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.

Journal: European journal of haematology

Published: May 12, 2025

Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel.

Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel.

Journal: Blood

Published: March 31, 2025

Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel.

Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel.

Journal: Blood

Published: March 31, 2025

Showing 1-12 of 152

Last Updated: 09/26/2026